[Methods for the preclinical screening of new anticancer agents].
Debussche
L
L
Programme de recherche en oncologie, Aventis Pharma, centre de recherche de Paris, 13, quai Jules-Guesde, BP 14, 94403 Vitry-sur-Seine.
D000818:Animals; D002471:Cell Transformation, Neoplastic; D002986:Clinical Trials as Topic; D004354:Drug Screening Assays, Antitumor; D015972:Gene Expression Regulation, Neoplastic; D015723:Gene Library; D006801:Humans; D023421:Models, Animal; D009363:Neoplasm Proteins / Q000032:analysis; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D009693:Nucleic Acid Hybridization; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000378:metabolism; D015398:Signal Transduction; D014158:Transcription, Genetic; D014162:Transfection
D009363:Neoplasm Proteins; D012333:RNA, Messenger